Publication:
EpideMiology and control measures of outBreaks due to Antibiotic-Resistant orGanisms in EurOpe (EMBARGO): a systematic review protocol.

dc.contributor.authorBabu Rajendran, Nithya
dc.contributor.authorGladstone, Beryl Primrose
dc.contributor.authorRodríguez-Baño, Jesús
dc.contributor.authorSifakis, Frangiscos
dc.contributor.authorVoss, Andreas
dc.contributor.authorCarmeli, Yehuda
dc.contributor.authorBurkert, Francesco Robert
dc.contributor.authorGkolia, Panagiota
dc.contributor.authorTacconelli, Evelina
dc.contributor.authoraffiliation[Babu Rajendran,N; Gladstone,BP; Burkert,FR; Gkolia,P; Tacconelli,A] Division of Infectious Diseases, Department of Internal Medicine 1, DZIF Partner Centre, University Hospital Tuebingen, Tuebingen, Germany. [Rodríguez-Baño,J] Department of Infectious Diseases and Clinical Microbiology, Hospital Universitario Virgen Macarena, Servicio Andaluz de Salud, Sevilla, Spain. [Sifakis,F] AstraZeneca, Gaithersburg, Maryland, USA. [Voss,A] Department of Clinical Microbiology and Infectious Diseases, Canisius-Wilhelmina Hospital. Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands. [Carmeli,Y] National Center for Antibiotic Resistance and Infection Control, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel.es
dc.contributor.funderThis research project receives support from the Innovative Medicines Initiative Joint Undertaking (IMI JU) under grant agreement numbers 115737(COMBACTE-MAGNET) and 115618 (DRIVE-AB), resources of which are composed of financial contribution from the European Union Seventh Framework Programme (FP7/2007-2013) and EFPIA companies in kind contribution. In addition as a special form of the IMI JU grant, FS received a direct financial contribution from AstraZeneca.
dc.date.accessioned2017-02-21T13:00:33Z
dc.date.available2017-02-21T13:00:33Z
dc.date.issued2017-01-05
dc.descriptionJournal Article; Erratum in: BMJ Open. 2017 Jan 27;7(1):e013634corr1es
dc.description.abstractINTRODUCTION Improving our understanding of outbreaks due to antibiotic-resistant bacteria (ARB) and their control is critical in the current public health scenario. The threat of outbreaks due to ARB requires multifaceted efforts. However, a global overview of epidemiological characteristics of outbreaks due to ARB and effective infection control measures is missing. In this paper, we describe the protocol of a systematic review aimed at mapping and characterising the epidemiological aspects of outbreaks due to ARB and infection control measures in European countries. METHODS AND ANALYSIS The databases MEDLINE, Web of Knowledge and Cochrane library will be searched using a 3-step search strategy. Selection of articles for inclusion will be performed by 2 reviewers using predefined eligibility criteria. All study designs will be included if they report an outbreak and define the microbiological methods used for microorganism identification. The target bacteria will be methicillin-resistant and vancomycin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, ceftazidime-resistant and carbapenem-resistant Acinetobacter baumannii, ceftazidime-resistant and carbapenem-resistant Pseudomonas aeruginosa, ciprofloxacin-resistant Escherichia coli, extended-spectrum β-lactamase-producing E. coli and Klebsiella pneumoniae, carbapenem-resistant and carbapenamase-producing Enterobacteriaceae. Data will be extracted using a tailored pilot tested form and the quality of reporting will be assessed using the ORION (Outbreak Reports and Intervention Studies Of Nosocomial infections) tool. Data will be synthesised and reported by the type of ARB, setting and country. Infection control measures and bundles of measures will be described. The effectiveness will be reported as defined by the authors. Regression analysis will be used to define independent factors associated with outbreaks' control. Heterogeneity between studies will be assessed by forest plots and I² statistics. ETHICS AND DISSEMINATION Ethical approval is not applicable for this study. Findings will be disseminated through journal publication and conference presentations and talks.es
dc.description.versionYeses
dc.identifier.citationBabu Rajendran N, Gladstone BP, Rodríguez-Baño J, Sifakis F, Voss A, Carmeli Y, et al. EpideMiology and control measures of outBreaks due to Antibiotic-Resistant orGanisms in EurOpe (EMBARGO): a systematic review protocol. BMJ Open. 2017; 7(1):e013634es
dc.identifier.doi10.1136/bmjopen-2016-013634
dc.identifier.essn2044-6055
dc.identifier.pmcPMC5223682
dc.identifier.pmid28057656
dc.identifier.urihttp://hdl.handle.net/10668/2586
dc.journal.titleBMJ Open
dc.language.isoen
dc.publisherBMJ Publishing Groupes
dc.relation.publisherversionhttp://bmjopen.bmj.com/content/bmjopen/7/1/e013634.full.pdfes
dc.rights.accessRightsopen access
dc.subjectEpidemiologyes
dc.subjectAcinetobacter baumanniies
dc.subjectCarbapenémicoses
dc.subjectCeftazidimaes
dc.subjectCiprofloxacinoes
dc.subjectInfección hospitalariaes
dc.subjectBrotes de enfermedadeses
dc.subjectResistencia a la meticilinaes
dc.subjectStaphylococcus aureus resistente a meticilinaes
dc.subject.meshMedical Subject Headings::Organisms::Bacteria::Gram-Negative Bacteria::Gram-Negative Aerobic Bacteria::Gram-Negative Aerobic Rods and Cocci::Moraxellaceae::Acinetobacter::Acinetobacter baumanniies
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agentses
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Organic Chemicals::Amides::Lactams::beta-Lactams::Carbapenemses
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Organic Chemicals::Amides::Lactams::beta-Lactams::Cephalosporins::Cephaloridine::Ceftazidimees
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 2-Ring::Quinolines::Quinolones::Fluoroquinolones::Ciprofloxacines
dc.subject.meshMedical Subject Headings::Diseases::Bacterial Infections and Mycoses::Infection::Cross Infectiones
dc.subject.meshMedical Subject Headings::Health Care::Environment and Public Health::Public Health::Disease Outbreakses
dc.subject.meshMedical Subject Headings::Organisms::Bacteria::Gram-Negative Bacteria::Gram-Negative Facultatively Anaerobic Rods::Enterobacteriaceaees
dc.subject.meshMedical Subject Headings::Organisms::Bacteria::Gram-Negative Bacteria::Gram-Negative Facultatively Anaerobic Rods::Enterobacteriaceae::Escherichia::Escherichia colies
dc.subject.meshMedical Subject Headings::Geographicals::Geographic Locations::Europees
dc.subject.meshMedical Subject Headings::Health Care::Environment and Public Health::Public Health::Public Health Practice::Communicable Disease Control::Infection Controles
dc.subject.meshMedical Subject Headings::Organisms::Bacteria::Gram-Negative Bacteria::Gram-Negative Facultatively Anaerobic Rods::Enterobacteriaceae::Klebsiella::Klebsiella pneumoniaees
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Microbiological Phenomena::Bacterial Physiological Phenomena::Drug Resistance, Bacterial::beta-Lactam Resistance::Penicillin Resistance::Methicillin Resistancees
dc.subject.meshMedical Subject Headings::Organisms::Bacteria::Endospore-Forming Bacteria::Gram-Positive Endospore-Forming Bacteria::Gram-Positive Endospore-Forming Rods::Staphylococcaceae::Staphylococcus::Staphylococcus aureus::Methicillin-Resistant Staphylococcus aureuses
dc.subject.meshMedical Subject Headings::Organisms::Bacteria::Gram-Negative Bacteria::Gram-Negative Aerobic Bacteria::Gram-Negative Aerobic Rods and Cocci::Pseudomonadaceae::Pseudomonas::Pseudomonas aeruginosaes
dc.subject.meshMedical Subject Headings::Disciplines and Occupations::Health Occupations::Medicine::Public Healthes
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Regression Analysises
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Carbohydrates::Glycoconjugates::Glycopeptides::Vancomycines
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Hydrolases::Amidohydrolases::beta-Lactamaseses
dc.titleEpideMiology and control measures of outBreaks due to Antibiotic-Resistant orGanisms in EurOpe (EMBARGO): a systematic review protocol.es
dc.typereview article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
BabuRajendranN_EpidemiologyControl.pdf
Size:
434.85 KB
Format:
Adobe Portable Document Format
Description:
Revisión